Company Overview and News

7
5 Reasons Why Helios and Matheson Analytics Inc Will Keep Crashing | InvestorPlace

7h investorplace
Helios and Matheson Analytics Inc (NASDAQ:HMNY) plunged again on Thursday. HMNY stock is down 33% as of this writing following its latest equity offering. The majority owner of the MoviePass movie ticket service is running into increasingly grave problems. While the stock’s decline is especially dramatic and may seem like a buying opportunity, here are the five reasons why you should steer clear of HMNY here.
Upvote Downvote

 
Decades-old Saudi cinema ban ends, public screenings start

10h bworldonline
RIYADH — Saudi Arabia launched its first commercial movie theater on Wednesday, ending a nearly 40-year ban on cinemas under a push by the crown prince to modernize the deeply conservative Muslim kingdom.
Upvote Downvote

 
UPDATE 1-Vox to open multiplex cinema in Riyadh in "coming days"

13h reuters
RIYADH, April 19 (Reuters) - Vox Cinemas, owned by Dubai’s Majid Al Futtaim, said on Thursday it had received a licence to operate cinemas in Saudi Arabia and would open a four-screen multiplex theatre in Riyadh “in the coming days”.
Upvote Downvote

 
UPDATE 1-Saudi Arabia launches first new cinema, public showings start Friday

2018-04-18 reuters
RIYADH (Reuters) - Saudi Arabia launched its first commercial movie theater on Wednesday, ending a nearly 40-year ban on cinemas under a push by the crown prince to modernize the deeply conservative Muslim kingdom.
Upvote Downvote

 
Saudi Arabia to launch first new cinema at private VIP event

2018-04-18 reuters
RIYADH (Reuters) - Saudi Arabia is launching its first commercial movie theater on Wednesday as it ends a nearly 40-year ban on cinemas under a push by the crown prince to open up the deeply conservative Muslim kingdom.
Upvote Downvote

 
Saudi Arabia ends 35-year movie ban

2018-04-18 abc.net.au
Saudi Arabia's 35-year ban on movies is coming to an end, with the premiere of Marvel's superhero film Black Panther.
Upvote Downvote

 
‘Black Panther’ in Saudi Arabia? Hollywood Sweeps Into Islamic Kingdom - WSJ

2018-04-16 wsj
On Wednesday, when moviegoers in Riyadh take their seats to watch a screening of Walt Disney Co.’s “Black Panther,” it will be the first time a Hollywood movie has played in a theater in Saudi Arabia in 35 years. AMC Entertainment Holdings Inc., the world’s largest movie theater company, is the first to operate in Saudi Arabia since a longtime ban on cinemas was lifted five months ago.
Upvote Downvote

1
The 7 Best Dividend Stocks for Monthly Income

2018-04-13 investorplace
Monthly dividend stocks are popular with investors – and with good reason. Monthly payments line up better with monthly bills, particularly for retirees living off investment income. Over time, there’s even a modest incremental benefit from compounding, particularly for investors successfully using DRIP plans.
Upvote Downvote

2
Mittleman Investment Management 1Q18 Commentary

2018-04-13 seekingalpha
Mittleman Investment Management, LLC's composite declined 11.3% net of fees in the first quarter of 2018, versus declines of 0.8% in the S&P 500 Total Return Index and 0.1% in the Russell 2000 Total Return Index. Longer-term results for our composite through 3/31/18 are presented below:
Upvote Downvote

 
The Zacks Analyst Blog Highlights: Paycom, Burlington and United States Cellular

2018-04-09 zacks
Chicago, IL – April 9, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Paycom Software, Inc. (PAYC - Free Report) , Burlington Stores, Inc. (BURL - Free Report) and United States Cellular Corporation (USM - Free Report) .
Upvote Downvote

 
The Zacks Analyst Blog Highlights: Alphabet, Chevron, Raytheon, Chubb and T. Rowe

2018-04-09 zacks
Chicago, IL – April 9, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Alphabet (GOOGL - Free Report) , Chevron (CVX - Free Report) , Raytheon (RTN - Free Report) , Chubb (CB - Free Report) and T. Rowe Price (TROW - Free Report) .
Upvote Downvote

 
Zacks.com featured highlights include: Abaxis, Haynes International, MakeMyTrip and Vectrus

2018-04-09 zacks
Chicago, IL – April 9, 2018 - Stocks in this week’s article Abaxis, Inc. (ABAX - Free Report) , Haynes International, Inc. (HAYN - Free Report) , MakeMyTrip Limited (MMYT - Free Report) and Vectrus, Inc. (VEC - Free Report) .
Upvote Downvote

 
Zacks Industry Outlook Highlights: Norfolk Southern, CSX, Kansas City, Genesee & Wyoming and Union Pacific

2018-04-09 zacks
Chicago, IL – April 9, 2018 – Today, Zacks Equity Research discusses the Industrial Metals, including Norfolk Southern Corp. (NSC - Free Report) , CSX Corp. (CSX - Free Report) , Kansas City Southern (KSU - Free Report) , Genesee & Wyoming, Inc. (GWR - Free Report) and Union Pacific Corp. (UNP - Free Report) .
Upvote Downvote

 
The Zacks Analyst Blog Highlights: Archer Daniels, Tyson Foods, Hormel, Campbell and Brown-Forman

2018-04-09 zacks
Chicago, IL – April 9, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Archer Daniels Midland Company (ADM - Free Report) , Tyson Foods, Inc. (TSN - Free Report) , Hormel Foods Corporation (HRL - Free Report) , Campbell Soup Company (CPB - Free Report) and Brown-Forman Corporation (BF.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 00165C104